Bryan T.R. Rowland - Mar 1, 2021 Form 4 Insider Report for Vertex, Inc. (VERX)

Role
GENERAL COUNSEL
Signature
/s/ Lisa Coleman, Attorney-in-Fact
Stock symbol
VERX
Transactions as of
Mar 1, 2021
Transactions value $
-$1,044,426
Form type
4
Date filed
11/12/2021, 03:22 PM
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERX Class A Common Stock Options Exercise $232K +62.2K +2363.07% $3.73* 64.8K Mar 17, 2021 Direct
transaction VERX Class A Common Stock Tax liability -$680K -26.5K -40.85% $25.67 38.3K Mar 17, 2021 Direct
transaction VERX Class A Common Stock Options Exercise $198K +62.4K +162.82% $3.17* 101K Mar 17, 2021 Direct
transaction VERX Class A Common Stock Tax liability -$795K -31K -30.57% $25.67 70.3K Mar 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERX Stock Option Options Exercise $0 -62.2K -50% $0.00 62.2K Mar 17, 2021 Class A Common Stock 62.2K $3.73 Direct F2
transaction VERX Stock Option Options Exercise $0 -62.4K -50% $0.00 62.4K Mar 17, 2021 Class A Common Stock 62.4K $3.17 Direct F3
transaction VERX Stock Option Award $0 +4.03K $0.00 4.03K Mar 1, 2021 Class A Common Stock 4.03K $32.16 Direct F4
transaction VERX Restricted Stock Units Award $0 +3.47K $0.00 3.47K Mar 1, 2021 Class A Common Stock 3.47K Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 53 shares of restricted stock that were inadvertently omitted from filer's Form 3 and 417 shares acquired through the Company's Employee Stock Purchase Plan. The amount reported in column 5 reflects the number of shares of Class A Common Stock beneficially owned as of the date hereof.
F2 This option became exercisable with respect to 50% of the shares on February 7, 2021, and will vest with respect to the remaining shares on February 7, 2024.
F3 This option became exercisable as to 50% of the shares on the date of grant and will vest with respect to the remaining shares on February 9, 2023.
F4 This option will vest and become exercisable with respect to 25% of the shares on each of March 1, 2022, March 1, 2023, March 1, 2024 and March 1, 2025.
F5 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F6 Represents an award of restricted stock units that will vest as to 50% of the amount of shares on March 1, 2023, and 25% of the shares on each of March 1, 2024 and March 1, 2025.